Table V.
Relationship between XPD-312 gene polymorphism and clinical characteristics of HCC.
| XPD-312 (n, %) | |||||
|---|---|---|---|---|---|
| Clinical features | AA | GA | GG | χ2 | P-value |
| General typing | 2.507 | 0.643 | |||
| Giant block type | 10 (18.18) | 4 (7.27) | 41 (74.55) | ||
| Nodular type | 11 (22.00) | 5 (10.00) | 34 (68.00) | ||
| Diffuse type | 18 (11.94) | 6 (8.96) | 52 (79.10) | ||
| No. of tumors | 19.309 | <0.001 | |||
| Single tumor | 19 (13.10) | 9 (6.21) | 117 (80.69) | ||
| Multiple tumors | 10 (37.04) | 6 (22.22) | 11 (40.74) | ||
| Liver tumor location | 11.831 | 0.019 | |||
| Left lobe | 12 (15.19) | 5 (6.33) | 62 (78.48) | ||
| Right lobe | 11 (15.94) | 4 (5.80) | 54 (78.26) | ||
| Other | 6 (25.00) | 6 (25.00) | 12 (50.00) | ||
| Tumor diameter | 19.502 | <0.001 | |||
| <5 cm | 11 (13.75) | 4 (5.00) | 65 (81.25) | ||
| 5-10 cm | 13 (17.11) | 6 (7.89) | 57 (75.00) | ||
| >10 cm | 6 (37.50) | 5 (31.25) | 5 (31.25) | ||
| Capsule invasion | 2.825 | 0.243 | |||
| Yes | 11 (18.33) | 8 (13.33) | 41 (68.33) | ||
| No | 18 (16.07) | 7 (6.25) | 87 (77.68) | ||
XPD, xeroderma pigmentosum complementary group D; HCC, hepatocellular carcinoma.